File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Compliance of disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: a longitudinal study.

TitleCompliance of disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: a longitudinal study.
Authors
Issue Date2016
PublisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/
Citation
The 21st Medical Research Conference (MRC 2016), Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 16 June 2016. In Hong Kong Medical Journal, 2016, v. 22 suppl. 1, p. 19, abstract no. 19 How to Cite?
AbstractINTRODUCTION: Compliance of disease-modifying anti-rheumatic drugs (DMARDs) could affect the effectiveness of DMARDs for the treatment of rheumatoid arthritis in real-life clinical setting. Factors affecting compliance vary in different population and health care systems. This study aimed to identify the characteristics of patients with and the factors contributing to lower degree of compliance to DMARDs. METHODS: This study was conducted in Queen Mary Hospital. For inclusion, patients must be diagnosed with rheumatoid arthritis and treated with at least one DMARD(s). Levels of compliance and beliefs about medications were assessed using 19-item Compliance Questionnaire Rheumatology and the Beliefs about Medicine Questionnaire (BMQ) respectively. Demographic variables, disease activities, and health states were collected during patient visits. Results were analysed by using SPSS v22.0. RESULTS: A total of 385 patients were recruited into this study. Female sex and young age (56.7 ± 0.66 vs 60.5 ± 1.90; P=0.038) were associated with low levels of compliance. Patients with low levels of compliance had poorer patients’ global health (36.0 ± 1.57 vs 25.8 ± 3.97; P=0.017), lower BMQ necessity score (17.6 ± 0.17 vs 21.5 ± 0.43; P < 0.001). There was no significant difference in terms of education levels, disease duration and activities, and number of DMARDs used as stratified by the level of compliance. CONCLUSION: Low level of compliance is characterised with female sex, young age, poorer patients’ global health, lower level of necessity, and higher level of concerns about DMARDs.
Persistent Identifierhttp://hdl.handle.net/10722/232472
ISSN
2015 Impact Factor: 0.887
2015 SCImago Journal Rankings: 0.279

 

DC FieldValueLanguage
dc.contributor.authorCheung, TT-
dc.contributor.authorTsoi, MF-
dc.contributor.authorCheung, BMY-
dc.date.accessioned2016-09-20T05:30:14Z-
dc.date.available2016-09-20T05:30:14Z-
dc.date.issued2016-
dc.identifier.citationThe 21st Medical Research Conference (MRC 2016), Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 16 June 2016. In Hong Kong Medical Journal, 2016, v. 22 suppl. 1, p. 19, abstract no. 19-
dc.identifier.issn1024-2708-
dc.identifier.urihttp://hdl.handle.net/10722/232472-
dc.description.abstractINTRODUCTION: Compliance of disease-modifying anti-rheumatic drugs (DMARDs) could affect the effectiveness of DMARDs for the treatment of rheumatoid arthritis in real-life clinical setting. Factors affecting compliance vary in different population and health care systems. This study aimed to identify the characteristics of patients with and the factors contributing to lower degree of compliance to DMARDs. METHODS: This study was conducted in Queen Mary Hospital. For inclusion, patients must be diagnosed with rheumatoid arthritis and treated with at least one DMARD(s). Levels of compliance and beliefs about medications were assessed using 19-item Compliance Questionnaire Rheumatology and the Beliefs about Medicine Questionnaire (BMQ) respectively. Demographic variables, disease activities, and health states were collected during patient visits. Results were analysed by using SPSS v22.0. RESULTS: A total of 385 patients were recruited into this study. Female sex and young age (56.7 ± 0.66 vs 60.5 ± 1.90; P=0.038) were associated with low levels of compliance. Patients with low levels of compliance had poorer patients’ global health (36.0 ± 1.57 vs 25.8 ± 3.97; P=0.017), lower BMQ necessity score (17.6 ± 0.17 vs 21.5 ± 0.43; P < 0.001). There was no significant difference in terms of education levels, disease duration and activities, and number of DMARDs used as stratified by the level of compliance. CONCLUSION: Low level of compliance is characterised with female sex, young age, poorer patients’ global health, lower level of necessity, and higher level of concerns about DMARDs.-
dc.languageeng-
dc.publisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/-
dc.relation.ispartofHong Kong Medical Journal-
dc.rightsHong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press.-
dc.titleCompliance of disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: a longitudinal study.-
dc.typeConference_Paper-
dc.identifier.emailCheung, TT: tcheungt@hku.hk-
dc.identifier.emailCheung, BMY: mycheung@hkucc.hku.hk-
dc.identifier.authorityCheung, TT=rp01682-
dc.identifier.authorityCheung, BMY=rp01321-
dc.identifier.hkuros265894-
dc.identifier.volume22-
dc.identifier.issuesuppl. 1-
dc.identifier.spage19, abstract no. 19-
dc.identifier.epage19, abstract no. 19-
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats